Precision BioSciences's market cap is currently $46.48M. The company's EPS TTM is $0.051; its P/E ratio is 115.26; Precision BioSciences is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $-2.25. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 48.73M	$ 25.10M	$ 115.53M	$ 24.29M	$ 22.24M
Gross Profit	$ 40.47M	$ 16.09M	$ 115.53M	$ 24.29M	$ 22.24M
Operating Income	$ -43.74M	$ -100.37M	$ -39.40M	$ -109.83M	$ -87.20M
EBITDA	$ -32.04M	$ -62.79M	$ -20.27M	$ -99.19M	$ -87.38M
Net Income	$ -61.32M	$ -122.91M	$ -30.92M	$ -109.01M	$ -83.30M
Balance Sheet
Cash & Short-Term Investments	$ 116.68M	$ 189.58M	$ 143.66M	$ 89.80M	$ 180.89M
Total Assets	$ 159.78M	$ 238.17M	$ 211.50M	$ 150.16M	$ 235.23M
Total Debt	$ 31.27M	$ 27.04M	$ 9.11M	$ 10.52M	$ 0.00
Net Debt	$ -85.41M	$ -162.54M	$ -134.55M	$ -79.28M	$ -180.89M
Total Liabilities	$ 140.92M	$ 177.74M	$ 120.33M	$ 105.73M	$ 96.92M
Stockholders' Equity	$ 18.86M	$ 60.43M	$ 91.17M	$ 44.42M	$ 138.31M
Cash Flow
Free Cash Flow	$ -86.39M	$ -49.07M	$ -16.66M	$ -92.42M	$ -95.68M
Operating Cash Flow	$ -84.11M	$ -45.75M	$ -10.85M	$ -87.39M	$ -71.02M
Investing Cash Flow	$ 5.83M	$ -3.32M	$ -5.80M	$ -5.03M	$ -24.67M
Financing Cash Flow	$ 5.39M	$ 94.98M	$ 70.52M	$ 1.33M	$ 173.37M

Currency in USD

Precision BioSciences Earnings and Revenue History

Income Statement >

Precision BioSciences Debt to Assets

Balance Sheet >

Precision BioSciences Cash Flow

Cash Flow >

Precision BioSciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing